Early-Stage Non-Small Cell Lung Cancer: Addressing the Imperfections

Thomas E. Stinchcombe, MD

January 30, 2023

Thomas E. Stinchcombe, MD, comments on unmet needs in the dynamic space of early-stage non–small cell lung cancer.

While crediting the more recent therapeutic advances, Dr Stinchcombe simultaneously laments the gaps in the understanding of the finer points of treatment efficacy and toxicities that prevents a more accurate and informative exchange with patients.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Early-Stage Non-Small Cell Lung Cancer: Addressing the Imperfections - Medscape - Jan 30, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Early-Stage Non-Small Cell Lung Cancer: Addressing the Imperfections

Tables

Authors and Disclosures

Authors and Disclosures

Expert

Thomas E. Stinchcombe, MD

Comments

Email This

Feedback